| Dr Carol Marie Loechinger, DC | |
|
7740 Washington Village Dr Ste 150, Dayton, OH 45459-3994 | |
| (937) 434-8700 | |
| (937) 434-2957 |
| Full Name | Dr Carol Marie Loechinger |
|---|---|
| Gender | Female |
| Speciality | Chiropractic |
| Experience | 48 Years |
| Location | 7740 Washington Village Dr Ste 150, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265585152 | NPI | - | NPPES |
| 0331975 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 654 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loechinger Chiropractic Clinic Inc | 3173549771 | 2 |
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
COVID-19 patients suffer from cognitive and behavioral problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology (EAN) has found.
A new treatment strategy for hypertension can cut the risk of strokes by around 25 percent and coronary events by around 15 percent according to the preliminary results of a major international trial announced at the American College of Cardiology Late Breaking Clinical Trials II Meeting in Orlando today.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the first quarter ended March 31, 2010.
› Verified 3 days ago
| Provider Name | Loechinger Chiropractic Clinic Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1790852036 PECOS PAC ID: 3173549771 Enrollment ID: O20051024000087 |
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
COVID-19 patients suffer from cognitive and behavioral problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology (EAN) has found.
A new treatment strategy for hypertension can cut the risk of strokes by around 25 percent and coronary events by around 15 percent according to the preliminary results of a major international trial announced at the American College of Cardiology Late Breaking Clinical Trials II Meeting in Orlando today.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the first quarter ended March 31, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carol Marie Loechinger, DC 180a E Spring Valley Pike, Dayton, OH 45458-3803 Ph: (937) 434-8700 | Dr Carol Marie Loechinger, DC 7740 Washington Village Dr Ste 150, Dayton, OH 45459-3994 Ph: (937) 434-8700 |
News Archive
Researchers at Columbia University's Mailman School of Public Health assessed the geographical distribution of the long-term burden of Post-Traumatic Stress Disorder in a region of Liberia and report that the prevalence of PTSD remains high nearly two decades after the principal conflict there and five years after war in Liberia ended entirely.
COVID-19 patients suffer from cognitive and behavioral problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology (EAN) has found.
A new treatment strategy for hypertension can cut the risk of strokes by around 25 percent and coronary events by around 15 percent according to the preliminary results of a major international trial announced at the American College of Cardiology Late Breaking Clinical Trials II Meeting in Orlando today.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the first quarter ended March 31, 2010.
› Verified 3 days ago
Dr. Patrick M Prikkel, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 2301 Far Hills Ave, Dayton, OH 45419 Phone: 937-293-2052 Fax: 937-293-1565 | |
Mark Vincent Scarano, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 30 W Rahn Road, 28, Dayton, OH 45429 Phone: 937-294-2828 Fax: 937-434-7607 | |
Steven Miller, Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5845 Far Hills Ave, Dayton, OH 45429 Phone: 800-404-6050 | |
Merkle Chiropractic Inc. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5785 Far Hills Ave, Dayton, OH 45429 Phone: 937-433-3241 Fax: 937-439-0088 | |
Dr. Gregory A. Goffe, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 380 Regency Ridge Dr, Dayton, OH 45459 Phone: 937-435-1895 Fax: 937-435-1884 | |
Ohio Health Solutions, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1129 Miamisburg Centerville Rd Ste 312, Dayton, OH 45449 Phone: 937-454-2048 | |
Mr. Steven Niyonkuru Jr., Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2206 Polo Park Dr, Dayton, OH 45439 Phone: 937-232-2265 Fax: 937-232-2265 |